Log in or Sign up for Free to view tailored content for your specialty!
Cornea/External Disease News
Phase 3 reproxalap trial meets ocular discomfort endpoint in patients with dry eye
Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.
Case study: Orbital lymphangioma manifests postpartum
Lymphangiomas, alternatively referred to as lymphatic malformations, are localized congenital benign lesions that affect the vascular and lymphatic systems and are characterized by multiple cysts.
Log in or Sign up for Free to view tailored content for your specialty!
BLOG: Current protocol: Aqueous-deficient dry eye
Over in my column The Dry Eye, I’ve embarked on a project to look at the basics of diagnosing and treating dry eye disease.
Yari has questions for Marjan Farid, MD: Navigating preoperative dry eye disease
Hi, I'm Yari, and I have questions, and this is Dr. Marjan Farid, and she has answers. Let's see if they match. Marjan, thank you for being here today.
BLOG: Post-refractive ectasia: Outcomes and expectations
Post-refractive ectasia is very rare. The incidence is only about 0.1% per 100,000 eyes undergoing LASIK and less than that in eyes undergoing PRK or SMILE.
HCP Cureblindness rebrands as Cure Blindness Project
HCP Cureblindness is rebranding as the Cure Blindness Project, according to a press release.
Eyenovia, Senju collaborate on chronic dry eye disease treatment
Eyenovia and Senju Pharmaceutical Co. have announced a collaboration agreement to develop Senju’s SJP-0035 for use with Eyenovia’s Optejet dispensing technology as a combination product to treat chronic dry eye disease.
BLOG: Trukera finds a new home: Maker of tear osmolarity test acquired by Bausch + Lomb
Anyone who has read any of my drivel knows that I am a long-time fan of testing tear osmolarity to guide the diagnosis and treatment of dry eye disease.
Bausch + Lomb acquires Trukera Medical
Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release.
World Sjögren’s Day shines light on a disease that too often goes years without diagnosis
Despite being the second-most common rheumatic autoimmune disease in the United States, Sjögren’s syndrome remains under-recognized, with patients often waiting 3 years for a proper diagnosis, according to the Sjögren’s Foundation.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read